Organization
Lutris Pharma
1 clinical trial
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform LesionsStatus: Recruiting, Estimated PCD: 2024-03-01